TLRY
Tilray Brands, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$4.50
−0.66%Margins
Gross margin
27.6%
EBITDA margin
1.4%
EBIT margin
-5.2%
Net margin
-12.9%
FCF margin
-9.9%
-9.2%
Return on equity
-6.4%
Return on assets
-3.0%
Return on invested capital
0.52x
Asset turnover
-$73.4M
Cash from operations
$1.68
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of May 1, 2026